Cargando…
A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers
Autores principales: | Lu, Yong-Chen, Parker, Linda, Lu, Tangying, Zheng, Zhili, Yao, Xin, Robbins, Paul F, van der Bruggen, Pierre, Klebanoff, Christopher A, Hinrichs, Christian S, Goff, Stephanie, Sherry, Richard, Kammula, Udai, Yang, James C, Rosenberg, Steven A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645267/ http://dx.doi.org/10.1186/2051-1426-3-S2-P158 |
Ejemplares similares
-
In silico characterization of immunogenic epitopes presented by HLA-Cw*0401
por: Tong, Joo Chuan, et al.
Publicado: (2007) -
Unique Clinical and Pathological Features in HLA-DRB1*0401–restricted MBP 111–129–specific Humanized TCR Transgenic Mice
por: Quandt, Jacqueline A., et al.
Publicado: (2004) -
TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets
por: Straetemans, Trudy, et al.
Publicado: (2012) -
Overexpressed Pseudogene HLA-DPB2 Promotes Tumor Immune Infiltrates by Regulating HLA-DPB1 and Indicates a Better Prognosis in Breast Cancer
por: Lyu, Lijuan, et al.
Publicado: (2020) -
HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort
por: Anagnostouli, Maria, et al.
Publicado: (2020)